Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,104 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Growth factors and their receptors in pancreatic cancer.
Ozawa F, Friess H, Tempia-Caliera A, Kleeff J, Büchler MW. Ozawa F, et al. Among authors: friess h. Teratog Carcinog Mutagen. 2001;21(1):27-44. doi: 10.1002/1520-6866(2001)21:1<27::aid-tcm4>3.0.co;2-9. Teratog Carcinog Mutagen. 2001. PMID: 11135319 Review.
Chronic pancreatitis--new pathophysiological concepts.
Berberat PO, Friess H, Büchler MW. Berberat PO, et al. Among authors: friess h. Swiss Surg. 2000;6(5):227-30. doi: 10.1024/1023-9332.6.5.227. Swiss Surg. 2000. PMID: 11077486 Review.
[Surgery of pancreatic carcinoma].
Wagner M, Kulli C, Friess H, Seiler CA, Büchler MW. Wagner M, et al. Among authors: friess h. Swiss Surg. 2000;6(5):264-70. doi: 10.1024/1023-9332.6.5.264. Swiss Surg. 2000. PMID: 11077494 Review. German.
[Transforming growth factor-beta controls pathogenesis of Crohn disease].
Friess H, di Mola FF, Egger B, Scheuren A, Kleeff J, Zimmermann A, Büchler MW. Friess H, et al. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:994-7. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931770 German.
[Pancreatic carcinoma: conclusive clinical consequences based on molecular biology knowledge for therapy].
Ketterer K, Friess H, Büchler MW. Ketterer K, et al. Among authors: friess h. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:405-10. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931650 Review. German.
[Efficacy and economic aspects of preoperative diagnosis: laparoscopy is useful in only 13% of patients with pancreatic carcinoma].
Friess H, Baer HU, Sadowski C, Büchler MW. Friess H, et al. Langenbecks Arch Chir Suppl Kongressbd. 1997;114:474-6. Langenbecks Arch Chir Suppl Kongressbd. 1997. PMID: 9574186 German.
[Prognosis in pancreatic carcinoma].
Friess H, Isenmann R, Berberat P, Kleeff J, Büchler MW. Friess H, et al. Ther Umsch. 1996 May;53(5):401-7. Ther Umsch. 1996. PMID: 8685859 Review. German.
Activity of raltitrexed and gemcitabine in advanced pancreatic cancer.
Kralidis E, Aebi S, Friess H, Büchler MW, Borner MM. Kralidis E, et al. Among authors: friess h. Ann Oncol. 2003 Apr;14(4):574-9. doi: 10.1093/annonc/mdg150. Ann Oncol. 2003. PMID: 12649104 Clinical Trial.
ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer.
Graber HU, Friess H, Kaufmann B, Willi D, Zimmermann A, Korc M, Büchler MW. Graber HU, et al. Among authors: friess h. Int J Cancer. 1999 Feb 19;84(1):24-7. doi: 10.1002/(sici)1097-0215(19990219)84:1<24::aid-ijc5>3.0.co;2-2. Int J Cancer. 1999. PMID: 9988227
bax, but not bcl-2, influences the prognosis of human pancreatic cancer.
Friess H, Lu Z, Graber HU, Zimmermann A, Adler G, Korc M, Schmid RM, Büchler MW. Friess H, et al. Gut. 1998 Sep;43(3):414-21. doi: 10.1136/gut.43.3.414. Gut. 1998. PMID: 9863489 Free PMC article.
1,104 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback